Andrew Laskowski has 15 years experience in the bioprocess industry, ranging from mAbs, to vaccines, and gene therapies. He has spent the past 12 years of his career with Pall Life Sciences, now Cytiva, supporting the iCELLis bioreactor franchise as a process development scientist, field application specialist, and now as the global product manager.  He has chemical and biomedical engineering degrees from the University of Michigan. He currently resides in Michigan with his wife and 3 children.